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INTRODUCTION
Acute promyelocytic leukemia (APL) is one of the commonest subtypes of acute myeloid leukemia (AML), with the vast majority of cases harboring the t (15;17) chromosomal translocation, involving the fusion of the genes encoding PML (promyelocytic leukemia) and the transcription factor RARα (retinoic acid receptor alpha) [1] [2] [3] . The outcome for APL patients has been transformed with the advent of molecularly-targeted therapies, i.e. arsenic trioxide (ATO) and all-trans retinoic acid (ATRA), which bind to the PML and RARα moieties of PML-RARα, respectively.
These two drugs act in synergy to trigger PML-RARα degradation, by promoting apoptosis (ATO) and cellular differentiation (ATRA), inducing clinical remission [4] [5] [6] [7] .
PML is localized in PML nuclear bodies (NBs) [8] [9] [10] , discrete subnuclear structures of which PML is a crucial component [11] [12] [13] . Indeed, PML not only promotes NB biogenesis and maintains its integrity 3, 14, 15 , but is also involved in the recruitment and localization of approximately one hundred proteins into this complex (e.g. SUMO-1, CBP, DAXX, BLM) 16 . The post-translational modifications of PML, including its SUMOylation, are critical steps in the formation of mature PML NBs 3, [17] [18] [19] . PML NBs are dynamic multiprotein complexes 16 , involved in various major processes such as stem cell self-renewal, cell death, and transcription 20 .
Cells utilize different DNA repair pathways depending on the type of damage, and the phase of the cell cycle in which the damage occurs. DNA double-strand breaks (DSBs) produced by ionizing radiation (IR), for example, can be repaired by two major mechanisms: the non-homologous end joining (NHEJ) and homologous recombination (HR) repair pathways. NHEJ, which is mostly active during the G1 phase of the cell cycle, mediates direct ligation of the broken DNA ends in an error 5 prone manner. HR is, by contrast, largely error free, and arises in the G2 phase using sister chromatids as templates for repair. Failure in DNA DSB repair may lead to genomic instability, and consequently cancer predisposition 21 .
Numerous studies have highlighted the importance of the capacity of the PML-RARα fusion protein to oligomerize (conferred by the PML moiety) in APL pathogenesis , in contrast to wild-type RARα which lacks this property 22, 23 . Moreover, it is also unambiguous that PML-RARα expression has a major impact on nuclear architecture leading to NB disruption into nuclear microspeckles, which is a diagnostic hallmark of APL 3 . This phenomenon has been proposed as a key step in leukemogenesis 24 , but this has not been formally explored in vivo until now. Furthermore, NB disruption is reversed by ATO or ATRA treatment 25 , suggesting that normalization of nuclear architecture may be important for response to targeted therapies. To address these issues, we have generated a novel knock-in mouse model, where targeted Pml NB disruption was achieved through mutation of two key zinc-binding cysteine residues (C62A/C65A) in the RING domain of Pml. Our mouse model highlights the essential cooperative role of the NB disruption induced by PML-RARα expression in APL development, and the importance of re-formation of NBs in generating an efficient response to differentiating drug (ATRA). Additionally, our data reveal that Pml NBs are determinants of the quality of DNA damage repair via both NHEJ and HR repair pathways.
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MATERIALS AND METHODS
Animal experimental guidelines
All animal experimentations were performed in accordance with the terms of UK Home Office guidelines. The home office project license number under which these experiments were conducted is PPL 70/7720.
Transplantation experiments
All transplant recipient mice were 8-12 weeks old at the time of transplantation.
Unfractionated BM cells (0. +p50-RARα; #1111/3, #935/5, and #1097/1 for PML-RARα.
For ATRA in vivo-experiments, placebo or ATRA 21-day release pellets (5 mg;
Innovative Research of America) were subcutaneously implanted 7 days posttransplantation as per manufacturer's instructions.
Immunoprecipitation and immunoblot analysis
Cells were lysed on ice in RIPA buffer containing protease inhibitor cocktail (Roche) and 20 mM NEM (Sigma-Aldrich). Lysates were pre-cleared with Sepharose 4B beads (GE Healthcare), and then immunoprecipitated with the relevant antibody or isotype control as previously described 26 . Immunoprecipitates and whole cell lysates were separated by SDS-PAGE and transferred to PVDF membranes (Millipore).
Membranes were blocked in 5% BSA, and then incubated with primary antibodies overnight at 4ºC. Immunodetection was performed using ECL Western blotting substrate (ThermoFisher), or using infrared imaging (Odyssey LI-COR).
Flow cytometry assays
LSK population was defined as previously described 27 . Briefly, lineage-depleted (Dynabeads, ThermoFisher) BM cells were stained with fluorochrome-conjugated antibodies against Sca-1, and c-Kit (Biolegend), and the lineage cocktail (B220, CD3, CD4, CD8, Ter119, Mac-1, and Gr-1; Biolegend). CD11b/Gr-1 population analysis was performed as previously described 28 . Flow cytometry was performed on a BD LSRFortessa cell analyzer and data were analyzed with FlowJo software (Tree Star).
In vivo cell cycle analysis
Mice were injected with 50 mg/kg EdU (5-ethynyl-2'-deoxyuridine) 2 h before BM harvest 29 . Cells were processed using a Click-iT EdU Flow Cytometry Assay kit (ThermoFisher).
Nitro blue tetrazolium (NBT) reduction assay
0.1% of NBT (Sigma-Aldrich) was added to leukemic BM cells on poly-D-lysine coated coverslips, and incubated in a 5% CO 2 incubator at 37°C. Images were taken under Eclipse Ti-E Inverted Imaging System (Nikon), and auto-analyzed with the NIS software. At least 1100 cells were counted per sample.
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NHEJ and HR activity assay
All cell types were nucleofected using Amaxa kit (Lonza) following the manufacturer's instructions. Briefly, cells were co-transfected with linearized NHEJ reporter plasmid or linearized HR reporter plasmid (kind gifts of Dr Vera Gorbunova;
U. Rochester) and pDsRed-Express-N1 plasmid (Clontech; as transfection efficiency control) as previously described 30, 31 . Lineage-depleted BM cells were isolated 12 h before nucleofection 32 . Flow cytometry was performed on a BD LSRFortessa cell analyzer and data were analyzed with FlowJo software (Tree Star). Figure 1A) . We confirmed that these differences did not result from variations in the level of protein expression ( Figure 1B) Figure 1C ).
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RESULTS
Generation of a Pml
The PML RING domain is essential for PML SUMOylation 14, 15, 37, 39 .
Immunoprecipitations of Sumo-1 or Sumo-2/3 revealed that endogenous Pml WT was SUMOylated in MEFs at basal level, and hyper-SUMOylated following ATO treatment ( Figure 1D) . Moreover, post-ATO treatment, Pml WT was found to be ubiquitinated. None of these smears of bands were detected in Pml C62A/C65A cells, or as expected in Pml -/-cells (negative control) 26 ( Figure 1D ). Collectively, we confirmed that the C62A/C65A mutation induces NB disruption in a fashion similar to that observed in the context of PML-RARα. These data also demonstrate that the integrity of the RING domain is required not only for PML SUMOylation, but also for the ATO induced-PML degradation pathway.
In vivo, Pml C62A/C65A mice did not exhibit alterations in peripheral blood count parameters. However, the number of Lin +p50-RARα genotypes, with a frequency at 18 months of 6.8% and 13.8%, respectively, leading to a penetrance comparable to that observed in PML-RARα transgenic models [40] [41] [42] (Figure 2A) . Moreover, the latency period before the onset of leukemia was significantly reduced in the context of NB disruption compared to Pml WT +p50-RARα (to 213 days of age versus 310 days; p<0.008; Figure 2A ).
These results demonstrate cooperativity between NB disruption and RARα dimerization in the initiation of APL.
We then assessed APL-initiating activity by transplanting primary APL-derived cells +p50-RARα-derived APL cells was confirmed by analysis of CD11b and Gr1 expression ( Figure   3B ). In vivo, ATRA-treated mice post-transplantation also confirmed these results:
survival was significantly improved only for PML-RARα and Pml WT +p50-RARα transplanted mice, compared to placebo-treated mice ( Figure 3C ). These data reveal 13 the importance of Pml NB re-formation for an effective response to the differentiating drug.
Pml NBs are involved in the maintenance of genome integrity and essential for optimal DNA DSB repair via the NHEJ and HR pathways
The PML-RARA translocation is undoubtedly an initiating event in APL pathogenesis, but is not sufficient by itself for the full development of APL. Indeed, it is now wellestablished that APL is a multistep disease, requiring additional cooperating mutations, thus explaining the long latency period prior to leukemia onset [44] [45] [46] [47] [48] . To determine whether the three different genotypes generated APL with similar mutational spectra, we performed whole-exome sequencing on samples from Pml WT +p50-RARα and Pml C62A/C65A +p50-RARα spontaneous leukemias, and on PML-RARα transplant samples. Interestingly, some of the mutated genes were common to human APL (e.g. Kras, Ptpn11 and Usp9y) or human AML (e.g. Pten and Jak2) [48] [49] [50] [51] , and some of the copy number variants were common to human APL/AML (e.g. Kdm6a and Ezh2) or human myelodysplastic syndromes (e.g. Cul1) 46, 52, 53 (supplemental Figure 4 and supplemental Table 1 ).
Then, we speculated that loss of NB integrity might affect DNA DSB repair pathways 13, 54 . To investigate the efficiency of the NHEJ and HR pathways, we used a well-established system of reporter assays 30, 31 . Pml -and PML-RARα-induced NB disruption.
To determine whether these defects in DNA DSB repair pathways were due to a reduced kinetics of repair and/or reduced quality of repair, we analyzed MEF metaphase spreads. First, these revealed a significantly greater number of chromosome aberrations in Pml C62A/C65A cells in response to ionizing radiation (IR), compared to Pml WT and Pml -/-cells ( Figure 4D ). Second, a significantly higher number of spontaneous sister chromatid exchange (SCEs) was also found in Pml C62A/C65A cells, compared to WT cells ( Figure 4E) . Additionally, the rate of SCE formation in Pml C62A/C65A cells was similar to that observed in Pml -/-cells.
Altogether, these data indicate that NB dispersion gives rise to a higher level of recombination activity in primary cells, and further suggests that mice lacking Pml
NBs may have an unstable genome. repair were identical for all genotypes studied (supplemental Figure 6A-B) . This result was confirmed by Western blot analyses, since equivalent levels of γH2AX, between genotypes, were observed at each time point (supplemental Figure 6C) .
Investigation of the defective NHEJ pathway in Pml
Examining the NHEJ pathway-specific factors, we found that the number of 53BP1
foci was altered in Pml C62A/C65A MEFs, with no variation in protein expression and Pml -/-compared to Pml WT lysates ( Figure 6F ).
Collectively, our data provide further evidence that Pml NBs are essential for effective DNA repair response, and that their disruption is in part responsible for the deficiency observed in the context of PML-RARα expression.
DISCUSSION
APL development is invariably associated with translocations of the RARA gene, and numerous studies have been carried out to determine how the resulting fusions contribute to the pathogenesis of this disease. These include studies of the importance of the fusion partners, but these have been directed more towards their oligomerization potential. As a result, the role played by Pml NB disruption in APL pathogenesis had not been studied in a comprehensive way. Nevertheless, two particular studies have provided preliminary evidence for the importance of Pml NB disruption in leukemogenesis. Using truncated versions of the PML-RARα fusion protein, they hypothesized that the PML moiety was required not solely for the dimerization of RARα, and that the observed Pml NB disruption might play an active role in APL pathogenesis 57, 58 . Here, we used a novel knock-in mouse model, in which Pml NBs are disrupted in a similar fashion to that observed in the context of PML-RARα expression, in order to dissect their impact.
Using this model, we showed definitive evidence for the involvement of Pml NB disruption in APL initiation, in synergy with the forced dimerization of RARα. We also showed that an effective response to ATRA treatment requires Pml NB integrity.
These data validate the proposed hypothesis that NBs contain essential factors for nuclear hormone receptor signal transduction 11, 59, 60 , and demonstrate that the wildtype Pml allele plays an important role in tumor regression following ATRA treatment for PML-RARα APL 61 . These points are of importance since ATRA and its derivatives are under investigation not only for the treatment of other AML subtypes 62, 63 , but also for other malignancies [64] [65] [66] [67] [68] . 77 . It would be of interest, therefore, to carry out further analyses of 53BP1 phosphorylation, the localization of its partners (e.g. Rif1), and indubitably the SUMOylation of 53BP1 itself 78, 79 , in order to establish the causes and consequences of this excess of 53BP1 foci. Moreover, 53BP1 dysregulation might also have repercussions in the HR pathway, since 53BP1 and Brca1 are key regulators of the balance between NHEJ and HR repair pathways during the S-G2 phases of the cell cycle [80] [81] [82] [83] [84] . Also, the SUMO pathway is an important regulator of Brca1 functions [85] [86] [87] .
Finally, the discrepancies observed between the absence of Pml NBs and their disruption (i.e. Pml -/-versus Pml C62A/C65A mutants) could also be linked to their distinct impact on Sumo-2/3: while Sumo-2/3 formed abnormally large foci in Pml -/-cells, a diffuse pattern was observed in Pml C62A/C65A cells (supplemental Figure   10A ). These data are consistent with the role of Pml as a dynamic anchor regulated by 
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